Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Head & Neck 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 92Triple Negative Breast Neoplasms 39Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 10Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Colorectal Neoplasms 6Melanoma 5Cholangiocarcinoma 5Sarcoma 4Prostatic Neoplasms 4Lung Neoplasms 4Inflammatory Breast Neoplasms 4Breast Neoplasms, Male 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Gallbladder Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Colonic Neoplasms 3Carcinoma, Hepatocellular 3Carcinoma, Ductal, Breast 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Mesothelioma, Malignant 2Mesothelioma 2Lymphoma, Non-Hodgkin 2

Interventions

tremelimumab 1durvalumab 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1EC regimen 1Cisplatin 1Carboplatin 1CP protocol 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Cisplatin × Breast × Clear all
NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡